Xenon Pharmaceuticals Inc (FRA:XP0)
€ 37.4 0 (0%) Market Cap: 2.82 Bil Enterprise Value: 2.19 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 50/100

Q4 2022 Xenon Pharmaceuticals Inc Earnings Call Transcript

Mar 01, 2023 / 09:30PM GMT
Release Date Price: €37.2 (+1.09%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q4 2022 Xenon Pharmaceuticals, Inc. Earnings Conference Call. I would now like to turn the call over to Sherry Aulin, CFO. Please go ahead.

Sherry Aulin
Xenon Pharmaceuticals Inc. - CFO

Good afternoon. Thank you for joining us on our call and webcast to discuss Xenon's Fourth Quarter and Full Year 2022 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer.

Ian will open today's call with a summary of progress across our pipeline. Chris Kenny will provide an overview of our XEN1101 Phase III epilepsy program as well as a brief summary of additional supporting X-TOLE data we released in December, and I will summarize our financial results, progress within our partnered programs and our anticipated company milestone events. Chris Von Seggern will be available during our Q&A session to address questions about our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot